Kichler Adam, Jang Sunguk
Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH, USA.
Clin Endosc. 2019 Sep;52(5):401-406. doi: 10.5946/ce.2018.103. Epub 2019 Jul 16.
Non-variceal upper gastrointestinal bleeding (NVUGIB) refers to blood loss from the gastrointestinal tract proximal to the ligament of Treitz due to lesions that are non-variceal in origin. The distinction of the bleeding source as non-variceal is important in numerous aspects, but none more so than endoscopic approaches for successful hemostasis. When a patient presents with acute overt blood loss, NVUGIB is a medical emergency, which requires immediate intervention. There have been major strides in pharmacologic and endoscopic interventions for successful induction and remission of hemostasis in the last two decades. Despite achieving tangible improvements, the burden of the disease and the consequent mortality remain high. To address endoscopic outcomes better, several new technologies have emerged and have been subsequently incorporated to the armamentarium of hemostatic tools. This study aims to provide a succinct review on novel technologies for endoscopic hemostasis.
非静脉曲张性上消化道出血（NVUGIB）是指由于非静脉曲张性病变导致的屈氏韧带近端胃肠道出血。将出血源区分为非静脉曲张性在许多方面都很重要，但对于成功止血的内镜治疗方法而言，这一点最为重要。当患者出现急性显性失血时，NVUGIB是一种医疗急症，需要立即进行干预。在过去二十年中，药物和内镜干预在成功诱导和实现止血缓解方面取得了重大进展。尽管取得了切实的改善，但该疾病的负担和随之而来的死亡率仍然很高。为了更好地解决内镜治疗效果问题，出现了几种新技术，并随后被纳入止血工具库中。本研究旨在对内镜止血的新技术进行简要综述。
